Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences Corp (EW), sold 8,950 shares at $78.06 ($699K) on 2025-08-18, disclosed to the SEC on 2025-08-18.
Scheduled sale ($699k) by Global President TAVR & Surg under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2024-11-05 | $1.6M | — | Filing → |
| EW | SELL | 2023-12-13 | $1.2M | — | Filing → |
| EW | SELL | 2023-11-13 | $1.1M | — | Filing → |